The obesity paradox in community-acquired bacterial pneumonia

被引:77
|
作者
Corrales-Medina, Vicente F. [1 ]
Valayam, Josemon [2 ]
Serpa, Jose A. [2 ]
Rueda, Adriana M. [3 ]
Musher, Daniel M. [2 ,3 ,4 ]
机构
[1] Univ Ottawa, Dept Med, Div Infect Dis, Ottawa Hosp, Ottawa, ON K1Y 4E9, Canada
[2] Baylor Coll Med, Dept Med, Houston, TX 77030 USA
[3] Michael E DeBakey Vet Affairs Med Ctr Houston, Infect Dis Sect, Houston, TX USA
[4] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA
关键词
Pneumonia; Body mass index; Obesity; Mortality; Outcomes; PROGNOSIS; MORTALITY; DISEASE;
D O I
10.1016/j.ijid.2010.09.011
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: The impact of obesity on the outcome of pneumonia is uncertain. Methods: We retrospectively identified 266 hospitalized patients with proven pneumococcal or Haemophilus community-acquired pneumonia who had at least one body mass index (BMI, kg/m(2)) value documented in the 3 months before admission. Patients were classified as underweight (BMI < 18.5), normal weight (BMI 18.5 to <25), overweight (BMI 25 to <30), or obese (BMI >= 30). The association of absolute BMI values and BMI categories with the mortality at 30 days after admission for pneumonia was investigated. Results: Increasing BMI values were associated with reduced 30-day mortality, even after adjustment for significant covariates (odds ratio 0.88, confidence interval 0.81-0.96; p < 0.01). There was a significant trend towards lower mortality in the overweight and obese (non-parametric trend, p = 0.02). Conclusions: Our data suggest that obesity may exert a protective effect against 30-day mortality from community-acquired bacterial pneumonia. (C) 2010 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:E54 / E57
页数:4
相关论文
共 50 条
  • [1] Community-acquired bacterial pneumonia
    Guerrero, RF
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1996, 57 : 68 - 72
  • [2] Obesity paradox in patients with community-acquired pneumonia: Is inflammation the missing link?
    Braun, Nina
    Hoess, Claus
    Kutz, Alexander
    Christ-Crain, Mirjam
    Thomann, Robert
    Henzen, Christoph
    Zimmerli, Werner
    Mueller, Beat
    Schuetz, Philipp
    NUTRITION, 2017, 33 : 304 - 310
  • [3] Drugs for community-acquired bacterial pneumonia
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2007, 49 (1266): : 62 - 64
  • [4] COMMUNITY-ACQUIRED BACTERIAL PNEUMONIA IN THE ELDERLY
    GLECKMAN, RA
    ROTH, RM
    PHARMACOTHERAPY, 1984, 4 (02): : 81 - 88
  • [5] Omadacycline for Community-Acquired Bacterial Pneumonia
    Stets, Roman
    Popescu, Monica
    Gonong, Joven R.
    Mitha, Ismail
    Nseir, William
    Madej, Andrzej
    Kirsch, Courtney
    Das, Anita F.
    Garrity-Ryan, Lynne
    Steenbergen, Judith N.
    Manley, Amy
    Eckburg, Paul B.
    Tzanis, Evan
    McGovern, Paul C.
    Loh, Evan
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (06): : 517 - 527
  • [6] Corticosteroids for community-acquired bacterial pneumonia
    Kalantari, Hossein
    Hassen, Getaw Worku
    ACADEMIC EMERGENCY MEDICINE, 2025, 32 (02) : 176 - 178
  • [7] No obesity paradox in patients with community-acquired pneumonia – secondary analysis of a randomized controlled trial
    Angel N. Borisov
    Claudine A. Blum
    Mirjam Christ-Crain
    Fahim Ebrahimi
    Nutrition & Diabetes, 12
  • [8] No obesity paradox in patients with community-acquired pneumonia - secondary analysis of a randomized controlled trial
    Borisov, Angel N.
    Blum, Claudine A.
    Christ-Crain, Mirjam
    Ebrahimi, Fahim
    NUTRITION & DIABETES, 2022, 12 (01)
  • [9] Community-acquired bacterial pneumonia in adults: An update
    Eshwara, Vandana Kalwaje
    Mukhopadhyay, Chiranjay
    Rello, Jordi
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2020, 151 (04) : 287 - 302
  • [10] Community-Acquired Bacterial Pneumonia: Is There Anything New?
    Liu, Hans
    JOURNAL OF FAMILY PRACTICE, 2017, 66 (04): : S10 - S15